<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03834831</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2018/8866</org_study_id>
    <nct_id>NCT03834831</nct_id>
  </id_info>
  <brief_title>Impact of Coenzyme Q10 and Selenium on Seminal Fluid and Semen Antioxidant Status</brief_title>
  <official_title>Impact of Coenzyme Q10 and Selenium on Seminal Fluid Parameters and Antioxidant Status in Men With Idiopathic Infertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sumer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sumer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was conducted to assess the impact of coenzyme Q10 and selenium on seminal fluid
      parameters and antioxidant status in infertile men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study was to assess the impact of coenzyme Q10 and selenium on seminal fluid
      parameters and antioxidant status in infertile men with idiopathic oligoasthenoteratospermia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">January 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open Label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Semen volume (WHO 2010 guidelines)</measure>
    <time_frame>3 months</time_frame>
    <description>Semen volume in ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm concentration in semen (WHO 2010 guidelines)</measure>
    <time_frame>3 months</time_frame>
    <description>Sperm concentration in million/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm motility in semen (WHO 2010 guidelines)</measure>
    <time_frame>3 months</time_frame>
    <description>Sperm motility (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm morphology in semen (WHO 2010 guidelines)</measure>
    <time_frame>3 months</time_frame>
    <description>Normal sperm morphology (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seminal plasma TAC (Colorimetric assays)</measure>
    <time_frame>3 months</time_frame>
    <description>Seminal plasma total antioxidant capacity in mmol/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seminal plasma CAT (Colorimetric assays)</measure>
    <time_frame>3 months</time_frame>
    <description>Seminal plasma catalase in U/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seminal plasma SOD (Colorimetric assays)</measure>
    <time_frame>3 months</time_frame>
    <description>Superoxide dismutase in U/ml</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Male Infertility</condition>
  <arm_group>
    <arm_group_label>Coenzyme Q10</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coenzyme Q10 200mg/day for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Selenium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Selenium mcg/day for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Coenzyme Q10</intervention_name>
    <description>Coenzyme Q10</description>
    <arm_group_label>Coenzyme Q10</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Selenium</intervention_name>
    <description>Selenium</description>
    <arm_group_label>Selenium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of infertility of at least 12 months despite regular unprotected intercourse.

          -  Oligoasthenoteratospermia was diagnosed by semen analysis showing abnormal sperm
             concentration (&lt;15 million/ml), progressive motility (&lt;32%), total motility (&lt;40%) and
             morphology (&lt;30% WHO criteria) as defined by WHO manual for semen analysis 2010

        Exclusion Criteria:

          -  Azoospermia,

          -  Varicocele,

          -  Genital tract infection,

          -  Cryptorchidism,

          -  Testicular trauma or scrotal surgery,

          -  Endocrine disorder,

          -  Systemic illness,

          -  Smoking

          -  The presence of female factor
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male infertility</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed T Alahmar</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sumer, Iraq</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fertility Unit, Babyl</name>
      <address>
        <city>Hilla</city>
        <zip>00964</zip>
        <country>Iraq</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <reference>
    <citation>Alshahrani S, Aldossari K, Al-Zahrani J, Gabr AH, Henkel R, Ahmad G. Interpretation of semen analysis using WHO 1999 and WHO 2010 reference values: Abnormal becoming normal. Andrologia. 2018 Mar;50(2). doi: 10.1111/and.12838. Epub 2017 Aug 3.</citation>
    <PMID>28771785</PMID>
  </reference>
  <reference>
    <citation>Alahmar AT. The effects of oral antioxidants on the semen of men with idiopathic oligoasthenoteratozoospermia. Clin Exp Reprod Med. 2018 Jun;45(2):57-66. doi: 10.5653/cerm.2018.45.2.57. Epub 2018 Jun 29. Review.</citation>
    <PMID>29984205</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 6, 2019</study_first_submitted>
  <study_first_submitted_qc>February 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sumer</investigator_affiliation>
    <investigator_full_name>Dr. Ahmed T Alahmar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Male infertility</keyword>
  <keyword>Coenzyme Q10</keyword>
  <keyword>Selenium</keyword>
  <keyword>Antioxidants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
    <mesh_term>Ubiquinone</mesh_term>
    <mesh_term>Coenzyme Q10</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Patients data are anonymous and in hold with the principal investigator</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

